Actinium Pharmaceuticals Inc. (NYSE: ATNM), a clinical-stage biopharmaceutical company that develops antibody radiation-conjugates (ARC), took part in the .
How Seattle Seeded A Life Sciences Boom bisnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bisnow.com Daily Mail and Mail on Sunday newspapers.
S Africa virus strain poses re-infection risk — study jamaicaobserver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamaicaobserver.com Daily Mail and Mail on Sunday newspapers.
South Africa virus strain poses re-infection risk : study
In a new study, which has not yet been peer reviewed, researchers in South Africa tested the variant found there called 501Y.V2 against blood plasma from recovered Covid-19 patients. AFP
Representative image: Reuters
The coronavirus variant detected in South Africa poses a significant re-infection risk and raises concerns over vaccine effectiveness, according to preliminary research January 20, as separate studies suggested the British strain would likely be constrained by immunisations.
Several new variants each with a cluster of genetic mutations have emerged in recent weeks, sparking fears over an increase in infectiousness as well as suggestions that the virus could begin to elude immune response, whether from prior infection or a vaccine.